Want full text access to this journal?
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
Robert W Cross, Thomas W Geisbert
No abstract text is available yet for this article.
July 9, 2019: Lancet Infectious Diseases
#2
Alassane Dicko, Brian Greenwood
No abstract text is available yet for this article.
July 9, 2019: Lancet Infectious Diseases
#3
Halidou Tinto, Walter Otieno, Samwel Gesase, Hermann Sorgho, Lucas Otieno, Edwin Liheluka, Innocent Valéa, Valentine Sing'oei, Anangisye Malabeja, Daniel Valia, Anne Wangwe, Emilia Gvozdenovic, Yolanda Guerra Mendoza, Erik Jongert, Marc Lievens, François Roman, Lode Schuerman, John Lusingu
BACKGROUND: Results from a previous phase 3 study showed efficacy of the RTS,S/AS01 vaccine against severe and clinical malaria in children (in 11 sites in Africa) during a 3-4-year follow-up. We aimed to investigate malaria incidence up to 7 years postvaccination in three of the sites of the initial study. METHODS: In the initial phase 3 study, infants aged 6-12 weeks and children aged 5-17 months were randomly assigned (1:1:1) to receive four RTS,S/AS01 doses (four-dose group), three RTS,S/AS01 doses and a comparator dose (three-dose group), or four comparator doses (control group)...
July 9, 2019: Lancet Infectious Diseases
#4
Laura K McMullan, Mike Flint, Ayan Chakrabarti, Lisa Guerrero, Michael K Lo, Danielle Porter, Stuart T Nichol, Christina F Spiropoulou, César Albariño
BACKGROUND: The ongoing Ebola virus outbreak in the Ituri and North Kivu Provinces of the Democratic Republic of the Congo, which began in July, 2018, is the second largest ever recorded. Despite civil unrest, outbreak control measures and the administration of experimental therapies and a vaccine have been initiated. The aim of this study was to test the efficacy of candidate therapies and diagnostic tests with the outbreak strain Ituri Ebola virus. Lacking a virus isolate from this outbreak, a recombinant Ituri Ebola virus was compared with a similarly engineered Makona virus from the 2013-16 outbreak...
July 9, 2019: Lancet Infectious Diseases
#5
Emma Birnie, Harjeet S Virk, Jelmer Savelkoel, Rene Spijker, Eric Bertherat, David A B Dance, Direk Limmathurotsakul, Brecht Devleesschauwer, Juanita A Haagsma, W Joost Wiersinga
BACKGROUND: Melioidosis is an infectious disease caused by the environmental bacterium Burkholderia pseudomallei. It is often fatal, with a high prevalence in tropical areas. Clinical presentation can vary from abscess formation to pneumonia and sepsis. We assessed the global burden of melioidosis, expressed in disability-adjusted life-years (DALYs), for 2015. METHODS: We did a systematic review of the peer-reviewed literature for human melioidosis cases between Jan 1, 1990, and Dec 31, 2015...
July 5, 2019: Lancet Infectious Diseases
#6
Adesola Yinka-Ogunleye, Olusola Aruna, Mahmood Dalhat, Dimie Ogoina, Andrea McCollum, Yahyah Disu, Ibrahim Mamadu, Afolabi Akinpelu, Adama Ahmad, Joel Burga, Adolphe Ndoreraho, Edouard Nkunzimana, Lamin Manneh, Amina Mohammed, Olawunmi Adeoye, Daniel Tom-Aba, Bernard Silenou, Oladipupo Ipadeola, Muhammad Saleh, Ayodele Adeyemo, Ifeoma Nwadiutor, Neni Aworabhi, Patience Uke, Doris John, Paul Wakama, Mary Reynolds, Matthew R Mauldin, Jeffrey Doty, Kimberly Wilkins, Joy Musa, Asheena Khalakdina, Adebayo Adedeji, Nwando Mba, Olubunmi Ojo, Gerard Krause, Chikwe Ihekweazu
BACKGROUND: In September, 2017, human monkeypox re-emerged in Nigeria, 39 years after the last reported case. We aimed to describe the clinical and epidemiological features of the 2017-18 human monkeypox outbreak in Nigeria. METHODS: We reviewed the epidemiological and clinical characteristics of cases of human monkeypox that occurred between Sept 22, 2017, and Sept 16, 2018. Data were collected with a standardised case investigation form, with a case definition of human monkeypox that was based on previously established guidelines...
July 5, 2019: Lancet Infectious Diseases
#7
Katherine B Gibney, Allen C Cheng
No abstract text is available yet for this article.
July 5, 2019: Lancet Infectious Diseases
#8
Giovanni Rezza
No abstract text is available yet for this article.
July 5, 2019: Lancet Infectious Diseases
#9
Alberto L Garcia-Basteiro, Helen E Jenkins, Moleboleng Rangaka
No abstract text is available yet for this article.
July 4, 2019: Lancet Infectious Diseases
#10
Gwenan M Knight, C Finn McQuaid, Peter J Dodd, Rein M G J Houben
BACKGROUND: To end the global tuberculosis epidemic, latent tuberculosis infection needs to be addressed. All standard treatments for latent tuberculosis contain drugs to which multidrug-resistant (MDR) Mycobacterium tuberculosis is resistant. We aimed to estimate the global burden of multidrug-resistant latent tuberculosis infection to inform tuberculosis elimination policy. METHODS: By fitting a flexible statistical model to tuberculosis drug resistance surveillance and survey data collated by WHO, we estimated national trends in the proportion of new tuberculosis cases that were caused by MDR strains...
July 4, 2019: Lancet Infectious Diseases
#11
Confronting the persisting threat of the Middle East respiratory syndrome to global health security.
Stanley Perlman, Esam I Azhar, Ziad A Memish, David S Hui, Alimuddin Zumla
No abstract text is available yet for this article.
July 3, 2019: Lancet Infectious Diseases
#12
Ecaterina Scarlatescu, Marcus D Lance
No abstract text is available yet for this article.
June 28, 2019: Lancet Infectious Diseases
#13
Tom E Fletcher, Hakan Leblebicioglu, Ilkay Bozkurt, Mustafa Sunbul, Heval Bilek, Zahide Asik, Sener Barut, Ferdi Gunes, Umit Gemici, Roger Hewson, Duncan Wilson, Matt K O'Shea, Tom Woolley, Brian Faragher, Kiran Parmar, David G Lalloo, Nick J Beeching, Beverley J Hunt
BACKGROUND: Data describing the coagulopathy of Crimean-Congo haemorrhagic fever are scarce. We did rotational thromboelastometry (ROTEM) and conventional coagulation testing in patients with Crimean-Congo haemorrhagic fever to increase our understanding of the coagulopathy of this infectious disease. METHODS: We did a prospective observational cohort study of adults aged 18 years and older and admitted to hospitals with PCR-confirmed Crimean-Congo haemorrhagic fever in Samsun and Tokat, Turkey...
June 28, 2019: Lancet Infectious Diseases
#14
REVIEW
Richard Hatchett, Nicole Lurie
The Coalition for Epidemic Preparedness Innovations (CEPI) was created as a result of an emerging global consensus that a coordinated, international, and intergovernmental effort was needed to develop and deploy new vaccines to prevent future epidemics. Although some disease outbreaks can be relatively brief, early outbreak response activities can provide important opportunities to make progress on vaccine development. CEPI has identified six such areas and is prepared to work with other organisations in the global community to combat WHO priority pathogens, including the hypothetical Disease X, by supporting early activities in these areas, even when vaccine candidates are not yet available...
June 27, 2019: Lancet Infectious Diseases
#15
Talha Burki
No abstract text is available yet for this article.
June 26, 2019: Lancet Infectious Diseases
#16
(no author information available yet)
No abstract text is available yet for this article.
June 19, 2019: Lancet Infectious Diseases
#17
REVIEW
Lydia H V Franklinos, Kate E Jones, David W Redding, Ibrahim Abubakar
More than 80% of the global population is at risk of a vector-borne disease, with mosquito-borne diseases being the largest contributor to human vector-borne disease burden. Although many global processes, such as land-use and socioeconomic change, are thought to affect mosquito-borne disease dynamics, research to date has strongly focused on the role of climate change. Here, we show, through a review of contemporary modelling studies, that no consensus on how future changes in climatic conditions will impact mosquito-borne diseases exists, possibly due to interacting effects of other global change processes, which are often excluded from analyses...
June 18, 2019: Lancet Infectious Diseases
#18
REVIEW
James A Seddon, Elizabeth Whittaker, Beate Kampmann, Deborah A Lewinsohn, Muhammad Osman, Anneke C Hesseling, Roxana Rustomjee, Farhana Amanullah
Following exposure to tuberculosis and subsequent infection, children often progress to tuberculosis disease more rapidly than adults. And yet the natural history of tuberculosis in children, as a continuum from exposure to infection and then to disease, is poorly understood. Children are rarely diagnosed with tuberculosis infection in routine care in international settings and few receive tuberculosis infection treatment. In this Personal View, we review the most up-to-date knowledge in three areas of childhood tuberculosis infection-namely, pathophysiology, diagnosis, and treatment...
June 17, 2019: Lancet Infectious Diseases
#19
Ulrike Wieland, Alexander Kreuter
No abstract text is available yet for this article.
June 13, 2019: Lancet Infectious Diseases
#20
Chunqing Lin, Jiri Slama, Paula Gonzalez, Marc T Goodman, Ningshao Xia, Aimée R Kreimer, Ting Wu, Nancy A Hessol, Yurii Shvetsov, Ana P Ortiz, Beatriz Grinsztejn, Anna-Barbara Moscicki, Isabelle Heard, María Del Refugio González Losa, Erna M Kojic, Maarten F Schim van der Loeff, Feixue Wei, Adhemar Longatto-Filho, Zizipho A Mbulawa, Joel M Palefsky, Annette H Sohn, Brenda Y Hernandez, Katina Robison, Steve Simpson, Lois J Conley, Alexandra de Pokomandy, Marianne A B van der Sande, Racheal S Dube Mandishora, Lays P B Volpini, Alessandra Pierangeli, Byron Romero, Timothy Wilkin, Silvia Franceschi, Carmen Hidalgo-Tenorio, Reshmie A Ramautarsing, Ina U Park, Fernanda K Tso, Sheela Godbole, Kathleen W M D'Hauwers, Borek Sehnal, Lynette J Menezes, Sandra A Heráclio, Gary M Clifford
BACKGROUND: Cervical cancer screening might contribute to the prevention of anal cancer in women. We aimed to investigate if routine cervical cancer screening results-namely high-risk human papillomavirus (HPV) infection and cytohistopathology-predict anal HPV16 infection, anal high-grade squamous intraepithelial lesions (HSIL) and, hence, anal cancer. METHODS: We did a systematic review of MEDLINE, Embase, and the Cochrane library for studies of cervical determinants of anal HPV and HSIL published up to Aug 31, 2018...
June 13, 2019: Lancet Infectious Diseases
Fetching more papers... 
